Evidence map›Paper›PMID 34438947›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant

Katie E Barber, Zade Shammout, Jordan R Smith, Razieh Kebriaei, Taylor Morrisette, Michael J Rybak

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Synergistic Action of Antimicrobial Peptides and Antibiotics.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. The emerging challenge ofClinical microbiology reviews · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Katie E BarberAnti-Infective Research Laboratory, School of Medicine, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI 48201, USA.ORCID 0000-0002-8411-3111
Zade ShammoutAnti-Infective Research Laboratory, School of Medicine, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI 48201, USA.
Jordan R SmithAnti-Infective Research Laboratory, School of Medicine, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI 48201, USA.ORCID 0000-0002-1789-3517
Razieh KebriaeiAnti-Infective Research Laboratory, School of Medicine, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI 48201, USA.
Taylor MorrisetteAnti-Infective Research Laboratory, School of Medicine, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI 48201, USA.
Michael J RybakAnti-Infective Research Laboratory, School of Medicine, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI 48201, USA.
Eugene Applebaum College of Pharmacy and Health Sciences · USHigh Point University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

methodsBroth microdilution (BMD) and biofilm MIC (bMIC) values for daptomycin, ampicillin, ceftriaxone, fosfomycin, and rifampin were determined against biofilm-producing

resultsDaptomycin bMICs were 2-8-fold higher than BMD. In the presence of other antimicrobials, daptomycin bMICs were reduced ≥ two-fold in dilutions. Ceftriaxone and ampicillin demonstrated the most potent combinations with daptomycin, yielding synergy against three of four strains. Daptomycin plus rifampin was synergistic against

conclusionsDaptomycin combinations with beta-lactams demonstrated promising synergistic activity against both

Indexed as

ampicillinbiofilmceftriaxonedaptomycinenterococcifosfomycinmedical devicerifampin

Identifiers

PMID34438947
PMCPMC8388763
OpenAlexW3184140040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.